YTE reported $2.92B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Chemocentryx CCXI:US $ 293.38M 23.75M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Cti Biopharma CTIC:US $ 99.04M 24.23M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Exelixis EXEL:US $ 1662.03M 68.78M
Gilead Sciences GILD:US $ 14200M 275M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Idera Pharmaceuticals IDRA:US $ 38.3M 5.18M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Newlink Genetics NLNK:US 105.75M 7.72M
Novartis NOVN:VX 26.25B 2.45B
Novartis NVS:US $ 26253M 2445M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
YTE INCY:US $ 2923.8M 303.74M